The AI Platform for Pharma Commercialization
BranchLab has raised $28.8M in total funding. The most recent round was Series A. The last funding was announced in May 2026.
BranchLab's investors include AIX Ventures, nvp capital, FCA Venture Partners, Sanofi Ventures, Swift Ventures.
BranchLab is headquartered in New York, United States.
The AI Platform for Pharma Commercialization
BranchLab is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BranchLab — Funding & Investors." VCBacked, May 13, 2026, https://www.vcbacked.co/company/branchlab. Accessed July 19, 2026.
VCBacked. (2026). BranchLab — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/branchlab
{{cite web |title=BranchLab — Funding & Investors |url=https://www.vcbacked.co/company/branchlab |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated